Promab biotechnologies

Ended Purchase Order Awarded

Contract number
HHSN272201701135P
Awardee
Awarding agency
Obligated
$5,650

Award facts

Contract value 100% obligated
$5,650.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
6509 Drugs And Biologicals, Veterinary Use
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $5,650 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Promab Biotechnologies, Inc. Promab Biotechnologies is a minority-owned, Asian-Pacific American-owned, for-profit small business that provides services such as antibody production, DNA synthesis, and subcloning for baculovirus and yeasts. The contract does not have a set-aside designation. Through this contract, Promab Biotechnologies will provide services to NIAID, likely related to its core capabilities in recombinant protein, antibody, and engineered cell line development and commercialization.

Quick answers

Who was awarded contract HHSN272201701135P?

HHSN272201701135P was awarded to Promab Biotechnologies, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 31, 2017.

How much is contract HHSN272201701135P worth?

The government has obligated $5,650 on HHSN272201701135P.

Was contract HHSN272201701135P competed?

The extent of competition for HHSN272201701135P was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award